Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
397.6 USD | -2.36% | +3.25% | +29.70% |
Apr. 24 | Baird Adjusts Medpace Price Target to $454 From $446, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Medpace Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024 |
Evolution of the average Target Price on Medpace Holdings, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Medpace Holdings, Inc.
Jefferies & Co. | |
Deutsche Bank Securities | |
UBS | |
Baird | |
Guggenheim | |
Truist Securities | |
Credit Suisse |
EPS Revisions
- Stock Market
- Equities
- MEDP Stock
- Consensus Medpace Holdings, Inc.